October 18, 2022Open Access
Ver artículo completoImpact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
PICO estructurado
Does empagliflozin improve decongestion and clinical benefit in patients hospitalized for acute heart failure?
P
Población
Patients hospitalized for acute heart failure (AHF)
I
Intervención
Empagliflozin
O
Resultado
Decongestion and clinical benefit at Day 90surrogate
Initiation of empagliflozin in acute heart failure provides early and sustained decongestion that is associated with clinical benefit at 90 days.
Resumen
Initiation of empagliflozin in patients hospitalized for AHF resulted in an early, effective and sustained decongestion which was associated with clinical benefit at Day 90.